Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology firm, has published findings in Nature Communications that establish circular single-stranded DNA (CssDNA) as a highly effective non-viral DNA donor template for gene integration in hematopoietic stem and progenitor cells (HSPCs). This research highlights the potential for […]










